AREAS OF EXPERTISE
Pharmaceutical Manufacturing Operations
Outsourcing Strategies
Quality Systems; Compliance Excellence
Operational Transformation
Operational Excellence – Lean Processes
Driving Operational Efficiencies
Building High Performing Teams
Organizational Restructuring
Budgeting and Planning
EXPERIENCE
xCell Strategic Consulting - President
Patheon Pharmaceuticals - Interim CEO
Patheon Pharmaceuticals - President, North America Commercial Operations
Wyeth Pharmaceuticals
SmithKline Beecham
ASSOCIATIONS
Member, International Leadership Forum of the ISPE
Member, International Society of Pharmaceutical Engineering (ISPE)
Member, Parenteral Drug Association (PDA)
EDUCATION
MBA, Philadelphia University
BS, Mechanical Engineering, Villanova University
|
|
|
Peter Bigelow, President
Peter has held executive leadership roles and provided management consultation within the biopharmaceutical, healthcare and consumer goods industries for over 28 years. His expertise includes global pharmaceutical manufacturing and supply chain operations, outsourcing strategies, quality systems, compliance excellence, building high performance teams, organizational restructuring, and driving operational efficiencies with lean processes.
Peter has been involved in major operational restructuring, has driven significant network wide improvements in Quality, Cost and Customer Service and has turned around underperforming factories. He has broad capabilities in driving change and managing Manufacturing and Supply Chain Operations.
|
Highlights:
-
Improved KPI results including a 10% improvement in Customer Service and Quality (RFT) in just nine months for a leading pharmaceutical company
-
Consolidated supplier base by 40% by establishing innovative management structure a large pharmaceutical company
-
Improved serious quality and supply issues by restructuring site and driving Operational Excellence Program while overseeing successful reinspections a leading pharmaceutical company
-
Led 2nd largest global P\pharmaceutical CMO/CRO and oversaw $700 million publicly traded company through leadership transition
-
Oversaw global manufacturing and supply chain operations for $3.0 billion worldwide consumer healthcare business for major products in US, Canada, Puerto Rico, Europe and China.
|
